France· FR:60862404
TECARTUS 0,4 - 2 x 100 000 000 cellules, dispersion pour perfusion
A medicinal product containing cellules autologues cd3+ transduites anti-cd19, registered in France by KITE PHARMA EU (PAYS-BAS).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CELLULES AUTOLOGUES CD3+ TRANSDUITES ANTI-CD19
- Manufacturer
- KITE PHARMA EU (PAYS-BAS)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009550772061 poche de cryoconservation EVA : éthylène vinyl acétate copolymère de 68 ml comprenant un tube d'alimentation flexible scellé et deux dispositifs de perfusion
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cellules autologues cd3+ transduites anti-cd19 in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesKYMRIAHNovartis Pharmaceuticals Corporation
- CanadaKYMRIAHNOVARTIS PHARMACEUTICALS CANADA INC
- SwitzerlandKymriah, Zellsuspension zur InfusionNovartis Pharma Schweiz AG
- CzechiaKYMRIAHNovartis Europharm Limited, Dublin
- SpainKYMRIAH 1,2 x 10e6 - 6,0 x 10e8 celulas dispersion para perfusionNovartis Europharm Limited
- FinlandKymriahNovartis Europharm Limited
- BelgiumKymriah 1,2 x 10*6 – 6 x 10*8 cellsNovartis Europharm
- United KingdomKymriah 1.2million-600million cells dispersion for infusion bagsNovartis Pharmaceuticals UK Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Kymriah
- Liechtenstein · Kymriah
- Norway · Kymriah
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dfbf322c-ebcc-4650-ac25-4430375e0ed4 GET /v1/drugs/dfbf322c-ebcc-4650-ac25-4430375e0ed4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60862404",
"date_amm": "2020-12-14",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/20/1492",
"substance": "CELLULES AUTOLOGUES CD3+ TRANSDUITES ANTI-CD19",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "dispersion pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about cellules autologues cd3+ transduites anti-cd19.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.